Navigation Links
Perrigo Confirms Filing for Generic Version of Gynazole-1® Cream and Announcement of Patent Infringement Lawsuit by KV Pharma
Date:7/30/2010

stomers."

Perrigo Company is a leading global healthcare supplier that develops, manufactures and distributes OTC and generic prescription (Rx) pharmaceuticals, nutritional products, and active pharmaceutical ingredients (API), and pharmaceutical and medical diagnostic products.  The Company is the world's largest manufacturer of OTC pharmaceutical products for the store brand market. The Company's primary markets and locations of manufacturing and logistics operations are the United States, Australia, Israel, Mexico and the United Kingdom. Visit Perrigo on the Internet (http://www.perrigo.com).

Note: Certain statements in this press release are forward-looking statements within the meaning of Section 21E of the Securities Exchange Act of 1934, as amended, and are subject to the safe harbor created thereby. These statements relate to future events or the Company's future financial performance and involve known and unknown risks, uncertainties and other factors that may cause the actual results, levels of activity, performance or achievements of the Company or its industry to be materially different from those expressed or implied by any forward-looking statements. In some cases, forward-looking statements can be identified by terminology such as "may," "will," "could," "would," "should," "expect," "plan," "anticipate," "intend," "believe," "estimate," "predict," "potential" or other comparable terminology. The Company has based these forward-looking statements on its current expectations, assumptions, estimates an
'/>"/>

SOURCE Perrigo Company
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Perrigo Announces Approval for Over-the-Counter Childrens Cetirizine Oral Solution
2. Perrigo and Partner Cobrek Confirms Filing for Generic Version of Evoclin(R) and Announcement of Lawsuit by Stiefel
3. Perrigo Announces FDA Final Approval for Polyethylene Glycol 3350
4. Perrigo Confirms Filing for Generic Version of Mens Rogaine(R) Foam
5. Perrigo Company Will Release First Quarter Fiscal 2010 Results on November 2, 2009
6. Perrigo Company Announces Dividend Increase
7. Perrigo Company Announces Quarterly Dividend
8. Perrigo Company Will Release Second Quarter Fiscal 2010 Results on February 2, 2010
9. Perrigo Company to Present at the 28th Annual J.P. Morgan Healthcare Conference
10. Perrigo Company To Present at the Sidoti Emerging Growth Conference
11. Perrigo Confirms Filing for Generic Version of Clobex(R) Spray and Announcement of Lawsuit by Galderma and Dermalogix
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/22/2014)... -- Prostate cancer is the second leading cause of cancer ... caught early - the problem is that too often ... Conditions Education Council (PCEC), – a national organization ... cancer screening –  is sponsoring its 25 th ... Committed to encouraging men to take ...
(Date:9/22/2014)... , Sept. 22, 2014 CytRx Corporation ... development company specializing in oncology, today announced that study ... clinical trials of aldoxorubicin, a pivotal global Phase 3 ... a global Phase 2b clinical trial in small cell ... for Medical Oncology (ESMO) 2014 Congress being held September ...
(Date:9/19/2014)... CHAPEL HILL, N.C. , Sept. 19, 2014 ... critical role in forging relationships with key opinion ... the market and competition. Despite the critical nature ... has created many challenges, including altering the landscape ... According to research, the oversight ...
Breaking Medicine Technology:PCEC Encourages Men Across America to Have a Baseline Prostate Health Assessment During the Annual Prostate Cancer Awareness Week 2PCEC Encourages Men Across America to Have a Baseline Prostate Health Assessment During the Annual Prostate Cancer Awareness Week 3CytRx Announces Presentation of Aldoxorubicin Global Phase 3 Soft Tissue Sarcomas and Global Phase 2b Small Cell Lung Cancer Trial Designs at ESMO 2014 Congress 2CytRx Announces Presentation of Aldoxorubicin Global Phase 3 Soft Tissue Sarcomas and Global Phase 2b Small Cell Lung Cancer Trial Designs at ESMO 2014 Congress 3CytRx Announces Presentation of Aldoxorubicin Global Phase 3 Soft Tissue Sarcomas and Global Phase 2b Small Cell Lung Cancer Trial Designs at ESMO 2014 Congress 4CytRx Announces Presentation of Aldoxorubicin Global Phase 3 Soft Tissue Sarcomas and Global Phase 2b Small Cell Lung Cancer Trial Designs at ESMO 2014 Congress 5CytRx Announces Presentation of Aldoxorubicin Global Phase 3 Soft Tissue Sarcomas and Global Phase 2b Small Cell Lung Cancer Trial Designs at ESMO 2014 Congress 6Role of Medical Science Liaisons Shifting in Healthcare Industry 2
... the annual,meeting of the Pediatric Academic Societies (PAS) shows ... the start of the typical flu,vaccination season -- healthcare ... children are already in the doctor,s office.,The potential impact ... that less than 20 percent of school-aged children between ...
... May 5 N30 Pharma (N30), a,biopharmaceutical company ... that target endogenous s-nitrosothiols,announced today that it has ... with mild to moderate asthma, as well as ... treatment of reactive and,obstructive airway diseases, including Cystic ...
Cached Medicine Technology:Starting Flu Vaccination in August Could Help Protect Nearly 11 Million More Children During Scheduled Doctors' Visits 2Starting Flu Vaccination in August Could Help Protect Nearly 11 Million More Children During Scheduled Doctors' Visits 3Starting Flu Vaccination in August Could Help Protect Nearly 11 Million More Children During Scheduled Doctors' Visits 4N30 Pharma Announces Completion of Phase 1 Clinical Studies With N30-201 2
(Date:9/22/2014)... three-quarters (74%) of parents are aware of online ... (28%) have used those online ratings to choose ... U-M research published today in Pediatrics . ... Children,s Hospital National Poll on Children,s Health, researchers ... physicians influenced their choices in seeking healthcare providers ...
(Date:9/22/2014)... a drug commonly used to treat diabetes, may raise ... among patients with an underactive thyroid, a new study ... may be associated with heart problems and broken bones, ... study. Among those in the study with an ... levels of thyroid-stimulating hormone per year compared with 322 ...
(Date:9/22/2014)... “The Race is On!” for the 22nd ... October 12, 2014 as it moves to its new location ... the signature fundraising and awareness event for Susan G. Komen® ... Race for the Cure provides supporters of all ages an ... even sleeping in. , “Moving the Race to Cesar ...
(Date:9/22/2014)... University of North Carolina at Chapel Hill researchers represents ... people who are experiencing the earliest stages of psychosis. ... development of severe mental disorders such as schizophrenia. Schizophrenia ... about 1 in every 100 people. In severe cases, ... life compromised, and the burden on family members can ...
(Date:9/22/2014)... Calif. The University of California, Riverside is one ... total of $2.5 million by the National ... zygomycetes ancient lineages of fungi that include plant ... wide variety of organic compounds. , Zygomycetes, used in ... to be among the first terrestrial fungi. Symbiotic associations ...
Breaking Medicine News(10 mins):Health News:Online ratings influence parents' choices of physicians for their children 2Health News:Diabetes Drug Metformin May Affect Thyroid in Some Patients 2Health News:22nd Annual Susan G. Komen Phoenix Race for the Cure® 2014 Moves to Downtown Phoenix 2Health News:22nd Annual Susan G. Komen Phoenix Race for the Cure® 2014 Moves to Downtown Phoenix 3Health News:Blood test may help determine who is at risk for psychosis 2Health News:Project launched to study evolutionary history of fungi 2Health News:Project launched to study evolutionary history of fungi 3Health News:Project launched to study evolutionary history of fungi 4
... has decided to include Genentech's breast cancer drug, Herceptin ... drug will now be subsidized throughout Australia. ... Australian women would be eligible to start using the ... the government about A$470 million ($356 million) by 2009. ...
... Since the start of the one child family policy in ... decreased, and a gross imbalance in the sex ratio// has ... ,The one child family policy has been in force in ... measure. To examine the impact of this policy, researchers analysed ...
... the Royal Adelaide Hospital may have found a cheap, ... aged care from becoming vitamin D deficient.// ... in the latest edition of the Medical Journal of ... Cleland, Clinical Professor at the Department of Medicine, University ...
... President of the Canadian Medical Association (CMA) said that Canadian ... health of their own children// although in general they rated ... to a survey carried out by Ipsos-Reid, commissioned by the ... kids aged 2-17 are obese/overweight, however only 9% of Canadian ...
... new warnings about the risk of psychotic behavior, heart ... on Monday. ,These drugs include Novartis ... Administration spokeswoman, Susan Bro said. ,She ... pressure. They must also include warnings about the risk ...
... shot on his family’s farm near Stowmarket Suffolk, has caused ... rabbit flu.// ,John Freeman, 29, had become infected ... a rabbit on his farm. His mother explained that he ... after three days. ,It was revealed by the ...
Cached Medicine News:Health News:Lower Birth Rate and Fewer Girls under China’s one Child Polic 2Health News:Improving Vitamin D Levels in Aged Care Residents 2Health News:New Alerts Needed for ADHD drugs 2
The MACS VA_500 (variable atmosphere) is primarily for the study and isolation of microaerophilic organisms,including Campylobacter spp,Helicobacter pylori and other similarly fastdious organisms....
... an electrical power supply, MERKUR offers a broad ... a gas spring for ease of operation. For ... a foot pedal hydraulic system. Thanks to its ... anytime in a highly mobile and flexible manner. ...
... table MARS Enduro is the ideal ... are required before, during or directly ... motorised longitudinal adjustment and the filigreed ... conditions in examination, induction and operating ...
... Top Rotation provides uncommon bi-directional flexibility, ... Hercules 6700B eliminates any conflicts between ... while providing ample leg room for ... procedures. Removable back and leg sections ...
Medicine Products: